533 related articles for article (PubMed ID: 33754147)
1. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
Hassan AO; Feldmann F; Zhao H; Curiel DT; Okumura A; Tang-Huau TL; Case JB; Meade-White K; Callison J; Chen RE; Lovaglio J; Hanley PW; Scott DP; Fremont DH; Feldmann H; Diamond MS
Cell Rep Med; 2021 Apr; 2(4):100230. PubMed ID: 33754147
[TBL] [Abstract][Full Text] [Related]
2. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
Hassan AO; Feldmann F; Zhao H; Curiel DT; Okumura A; Tang-Huau TL; Case JB; Meade-White K; Callison J; Lovaglio J; Hanley PW; Scott DP; Fremont DH; Feldmann H; Diamond MS
bioRxiv; 2021 Jan; ():. PubMed ID: 33532770
[TBL] [Abstract][Full Text] [Related]
3. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Hassan AO; Kafai NM; Dmitriev IP; Fox JM; Smith BK; Harvey IB; Chen RE; Winkler ES; Wessel AW; Case JB; Kashentseva E; McCune BT; Bailey AL; Zhao H; VanBlargan LA; Dai YN; Ma M; Adams LJ; Shrihari S; Danis JE; Gralinski LE; Hou YJ; Schäfer A; Kim AS; Keeler SP; Weiskopf D; Baric RS; Holtzman MJ; Fremont DH; Curiel DT; Diamond MS
Cell; 2020 Oct; 183(1):169-184.e13. PubMed ID: 32931734
[TBL] [Abstract][Full Text] [Related]
4. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
[TBL] [Abstract][Full Text] [Related]
5. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
bioRxiv; 2020 Dec; ():. PubMed ID: 33299991
[TBL] [Abstract][Full Text] [Related]
6. Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre-Fusion Spike Glycoproteins Protects Non-Human Primates against SARS-CoV-2 Infection.
Wang S; Qin M; Xu L; Mu T; Zhao P; Sun B; Wu Y; Song L; Wu H; Wang W; Liu X; Li Y; Yang F; Xu K; He Z; Klein M; Wu K
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766104
[TBL] [Abstract][Full Text] [Related]
7. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice.
Hassan AO; Shrihari S; Gorman MJ; Ying B; Yuan D; Raju S; Chen RE; Dmitriev IP; Kashentseva E; Adams LJ; Mann C; Davis-Gardner ME; Suthar MS; Shi PY; Saphire EO; Fremont DH; Curiel DT; Alter G; Diamond MS
Cell Rep; 2021 Jul; 36(4):109452. PubMed ID: 34289385
[TBL] [Abstract][Full Text] [Related]
8. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Mercado NB; Zahn R; Wegmann F; Loos C; Chandrashekar A; Yu J; Liu J; Peter L; McMahan K; Tostanoski LH; He X; Martinez DR; Rutten L; Bos R; van Manen D; Vellinga J; Custers J; Langedijk JP; Kwaks T; Bakkers MJG; Zuijdgeest D; Rosendahl Huber SK; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Hoffman E; Jacob-Dolan C; Kirilova M; Li Z; Lin Z; Mahrokhian SH; Maxfield LF; Nampanya F; Nityanandam R; Nkolola JP; Patel S; Ventura JD; Verrington K; Wan H; Pessaint L; Van Ry A; Blade K; Strasbaugh A; Cabus M; Brown R; Cook A; Zouantchangadou S; Teow E; Andersen H; Lewis MG; Cai Y; Chen B; Schmidt AG; Reeves RK; Baric RS; Lauffenburger DA; Alter G; Stoffels P; Mammen M; Van Hoof J; Schuitemaker H; Barouch DH
Nature; 2020 Oct; 586(7830):583-588. PubMed ID: 32731257
[TBL] [Abstract][Full Text] [Related]
9. Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.
Gagne M; Flynn BJ; Andrew SF; Flebbe DR; Mychalowych A; Lamb E; Davis-Gardner ME; Burnett MR; Serebryannyy LA; Lin BC; Pessaint L; Todd JM; Ziff ZE; Maule E; Carroll R; Naisan M; Jethmalani Y; Case JB; Dmitriev IP; Kashentseva EA; Ying B; Dodson A; Kouneski K; Doria-Rose NA; O'Dell S; Godbole S; Laboune F; Henry AR; Marquez J; Teng IT; Wang L; Zhou Q; Wali B; Ellis M; Zouantchangadou S; Ry AV; Lewis MG; Andersen H; Kwong PD; Curiel DT; Foulds KE; Nason MC; Suthar MS; Roederer M; Diamond MS; Douek DC; Seder RA
bioRxiv; 2023 Nov; ():. PubMed ID: 37986823
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).
Sunagar R; Prasad SD; Ella R; Vadrevu KM
Front Immunol; 2022; 13():1063679. PubMed ID: 36569867
[TBL] [Abstract][Full Text] [Related]
11. A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.
Ying B; Darling TL; Desai P; Liang CY; Dmitriev IP; Soudani N; Bricker T; Kashentseva EA; Harastani H; Schmidt AG; Curiel DT; Boon ACM; Diamond MS
bioRxiv; 2023 May; ():. PubMed ID: 37205450
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection.
Wang S; Xu L; Mu T; Qin M; Zhao P; Xie L; Du L; Wu Y; Legrand N; Mouchain K; Fichet G; Liu Y; Yin W; Zhao J; Ji M; Gong B; Klein M; Wu K
Front Cell Infect Microbiol; 2022; 12():979641. PubMed ID: 36405962
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
[TBL] [Abstract][Full Text] [Related]
14. Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?
Brüssow H
Microb Biotechnol; 2023 Jan; 16(1):3-14. PubMed ID: 36464938
[TBL] [Abstract][Full Text] [Related]
15. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
Nambulli S; Escriou N; Rennick LJ; Demers MJ; Tilston-Lunel NL; McElroy AK; Barbeau DJ; Crossland NA; Hoehl RM; Schrauf S; White AG; Borish HJ; Tomko JA; Frye LJ; Scanga CA; Flynn JL; Martin A; Gerke C; Hartman AL; Duprex WP
J Virol; 2024 May; 98(5):e0176223. PubMed ID: 38563762
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
Front Immunol; 2022; 13():995235. PubMed ID: 36172368
[TBL] [Abstract][Full Text] [Related]
17. A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts.
Schultz MD; Suschak JJ; Botta D; Silva-Sanchez A; King RG; Detchemendy TW; Meshram CD; Foote JB; Zhou F; Tipper JL; Zhang J; Harrod KS; Leal SM; Randall TD; Roberts MS; Georges B; Lund FE
Hum Vaccin Immunother; 2022 Nov; 18(6):2127292. PubMed ID: 36194255
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.
Park JG; Oladunni FS; Rohaim MA; Whittingham-Dowd J; Tollitt J; Hodges MDJ; Fathallah N; Assas MB; Alhazmi W; Almilaibary A; Iqbal M; Chang P; Escalona R; Shivanna V; Torrelles JB; Worthington JJ; Jackson-Jones LH; Martinez-Sobrido L; Munir M
iScience; 2021 Sep; 24(9):102941. PubMed ID: 34368648
[TBL] [Abstract][Full Text] [Related]
19. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L
Front Immunol; 2021; 12():697074. PubMed ID: 34262569
[TBL] [Abstract][Full Text] [Related]
20. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.
Feng L; Wang Q; Shan C; Yang C; Feng Y; Wu J; Liu X; Zhou Y; Jiang R; Hu P; Liu X; Zhang F; Li P; Niu X; Liu Y; Zheng X; Luo J; Sun J; Gu Y; Liu B; Xu Y; Li C; Pan W; Zhao J; Ke C; Chen X; Xu T; Zhong N; Guan S; Yuan Z; Chen L
Nat Commun; 2020 Aug; 11(1):4207. PubMed ID: 32826924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]